Comparison of Paricalcitol (I.V) and Alfacalcidol (I.V) in Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients [PDF]
Journal of Rawalpindi Medical College, 2020 Objective of study: To Compare the efficacy of Alfacalcidol (I.V) and Paricalcitol (I.V) for the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis patients.
Mansoor Abbas Qaisar +4 more
doaj +2 more sources
Alfacalcidol modulates oxidative stress parameters in the peripheral blood of patients with active rheumatoid arthritis [PDF]
Journal of the Serbian Chemical Society, 2016 Hormone D and its analogues display immunomodulatory activities providing a beneficial effect in immunoinflammatory diseases. The aim of this study was to assess the effect of alfacalcidol treatment on superoxide dismutase (SOD), catalase (CAT) and ...
Živanović-Radnić Tatjana +8 more
doaj +2 more sources
Osteoporosis and Sarcopenia, 2021 Objectives: To compare the effect of eldecalcitol and alfacalcidol on skeletal microstructure by high-resolution peripheral QCT (HR-pQCT). Methods: This was a substudy of a randomized, double-blind, active comparator trial.
Xiaolin Ni +9 more
doaj +2 more sources
Retrospective study on the treatment of osteoporotic vertebral compression fractures with alfacalcidol and percutaneous kyphoplasty [PDF]
Frontiers in SurgeryObjectiveTo evaluate the clinical efficacy of percutaneous kyphoplasty (PKP) combined with alfacalcidol in the treatment of osteoporotic vertebral compression fractures (OVCF), and to explore the impact on bone metabolism and functional recovery ...
Sihua Jin +6 more
doaj +2 more sources
Molecules, 2009 Alfacalcidol (1α-hydroxyvitamin D3) has been widely used since 1981 as a prodrug for calcitriol (1α,25-dihydroxyvitamin D3) in the treatment of hypocalcemia, chronic renal failure, hypoparathyroidism and osteoporosis.
Noboru Kubodera
exaly +3 more sources
Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis [PDF]
Frontiers in PharmacologyBackgroundThe objective of this study was to conduct a systematic review and network meta-analysis (NMA) to compare the efficacy of various anti-osteoporosis drugs in preventing femoral periprosthetic bone loss following total hip arthroplasty (THA ...
Zhi-Hu Zhao +5 more
doaj +2 more sources
Korelasi Kekuatan Otot Menggenggam dengan Otot Levator Ani pada Penderita Prolapsus Organ Panggul
Obgynia, 2023 Tujuan: Penelitian ini bertujuan mengetahui perbedaan kekuatan otot levator ani dan otot menggenggam sebelum dan sesudah pemberian analog vitamin D3 (alfacalcidol) dan mengetahui korelasi antara kekuatan kontraksi otot levator ani dan kekuatan kontraksi ...
Lulu Nurul Ula +2 more
doaj +1 more source
Comparison between paricalcitol versus cinacalcet therapy in the management of secondary hyperparathyroidism among prevalent hemodialysis patients [PDF]
Journal of Nephropharmacology, 2022 Introduction: Secondary hyperparathyroidism (SHPT) is one of the components of chronic kidney disease–mineral bone disorder (CKD-MBD) with significant contribution to the morbidity and mortality among prevalent hemodialysis (HD) patients.
Maha A. Behairy +3 more
doaj +1 more source
Scientific Reports, 2022 In the Japan Dialysis Active Vitamin D (J-DAVID) trial, oral alfacalcidol numerically, but not significantly, increased the risk of cardiovascular events among patients undergoing hemodialysis.
Tatsufumi Oka +11 more
doaj +1 more source
Effect of alfacalcidol on bone regeneration in senile rats
Bolʹ, Sustavy, Pozvonočnik, 2022 Background. Among the drugs that have a pleiotropic effect on bone, attention is drawn to alfacalcidol – the precursor of the active form of D-hormone.
F.V. Klymovytskyy +2 more
doaj +1 more source